Complete Filing Data
Foghorn Therapeutics Inc. reported Stockholders Equity of -$108.50 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Foghorn Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$74.3M | -$86.6M | -$98.4M | -$108.9M | -$101.3M | -$68.8M | -$51.1M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$111.0K | $961.0K | $3.2M | -$4.0M | -$3.0K | -$7.0K | |
| Research And Development Expense | $85.5M | $94.5M | $109.7M | $105.6M | $80.3M | $57.7M | $44.4M |
| Operating Income Loss | -$86.4M | -$102.7M | -$107.9M | -$117.1M | -$100.7M | -$68.5M | -$51.1M |
| Operating Expenses | $117.3M | $125.3M | $142.1M | $136.4M | $102.1M | $69.0M | $51.1M |
| Nonoperating Income Expense | $12.1M | $16.1M | $13.7M | $8.3M | -$586.0K | -$269.0K | -$44.0K |
| General And Administrative Expense | $27.6M | $28.4M | $32.4M | $30.7M | $21.7M | $11.2M | $6.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $30.9M | $22.6M | $34.2M | $19.2M | $1.3M | $430.0K | |
| Comprehensive Income Net Of Tax | -$74.4M | -$85.7M | -$95.3M | -$112.9M | -$101.3M | -$68.8M | -$51.1M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$111.0K | $961.0K | $3.2M | -$4.0M | -$3.0K | -$7.0K | |
| Interest Expense | $1.9M | $979.0K | $540.0K | ||||
| Income Tax Expense Benefit | $0.00 | $4.2M | $0.00 | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$86.6M | -$94.2M | -$108.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$15.8M | -$17.9M | -$18.8M | -$19.1M | -$23.0M | -$25.0M | -$14.3M | -$29.5M | -$30.5M | -$25.8M | -$27.3M | -$26.9M | -$26.1M | -$23.1M | -$23.0M | -$18.4M | -$15.7M | -$14.0M | -$13.1M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $68.0K | -$58.0K | -$121.0K | $698.0K | $159.0K | $329.0K | $826.0K | $151.0K | $1.1M | -$1.7M | -$2.0M | -$1.2M | -$3.0K | -$16.0K | $13.0K | $0.00 | $0.00 | $0.00 | |
| Research And Development Expense | $20.0M | $21.8M | $21.6M | $24.7M | $23.8M | $25.5M | $26.3M | $29.2M | $30.0M | $26.9M | $26.0M | $24.5M | $20.5M | $18.6M | $18.7M | $16.1M | $13.6M | $11.5M | $11.3M |
| Operating Income Loss | -$18.5M | -$21.1M | -$22.9M | -$23.9M | -$26.6M | -$28.2M | -$17.1M | -$32.1M | -$33.3M | -$28.3M | -$29.2M | -$27.8M | -$26.3M | -$23.3M | -$23.1M | -$18.5M | -$15.5M | -$13.7M | -$13.1M |
| Operating Expenses | $26.7M | $28.7M | $28.9M | $31.7M | $33.5M | $33.2M | $34.6M | $37.6M | $38.6M | $34.9M | $33.7M | $31.7M | $26.3M | $23.5M | $23.4M | $18.7M | $15.5M | $13.7M | $13.1M |
| Nonoperating Income Expense | $2.7M | $3.2M | $4.1M | $4.7M | $3.7M | $3.2M | $3.5M | $3.5M | $3.4M | $2.5M | $1.9M | $890.0K | $181.0K | $150.0K | $144.0K | $122.0K | -$184.0K | -$228.0K | $8.0K |
| General And Administrative Expense | $6.7M | $6.9M | $7.2M | $7.0M | $7.3M | $7.7M | $8.3M | $8.4M | $8.6M | $8.0M | $7.7M | $7.2M | $5.8M | $4.9M | $4.7M | $2.6M | $1.9M | $2.2M | $1.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $8.2M | $7.6M | $6.0M | $7.8M | $6.9M | $5.1M | $17.5M | $5.6M | $5.3M | $6.6M | $4.5M | $3.9M | $41.0K | $279.0K | $286.0K | $179.0K | $0.00 | $0.00 | |
| Comprehensive Income Net Of Tax | -$15.8M | -$18.0M | -$19.0M | -$18.4M | -$22.8M | -$24.7M | -$13.5M | -$29.3M | -$29.4M | -$27.4M | -$29.3M | -$28.1M | -$26.1M | -$23.1M | -$23.0M | -$18.4M | -$15.7M | -$14.0M | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $68.0K | -$58.0K | -$121.0K | $698.0K | $159.0K | $329.0K | $826.0K | $151.0K | $1.1M | -$1.7M | -$2.0M | -$1.2M | -$3.0K | -$16.0K | $13.0K | $0.00 | $0.00 | $0.00 | |
| Interest Expense | $0.00 | $0.00 | $0.00 | $499.0K | $495.0K | $486.0K | $202.0K | $198.0K | $258.0K | $113.0K | |||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $738.0K | $942.0K | $560.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$19.1M | -$23.0M | -$25.0M | -$13.6M | -$28.5M | -$29.9M | -$25.8M | -$27.3M | -$26.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$108.5M | -$45.5M | -$77.2M | $112.0K | $96.9M | $146.2M | -$88.0M | -$39.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $84.1M | $57.2M | $82.0M | $53.9M | $102.9M | $94.5M | $17.3M | $40.6M |
| Cash And Cash Equivalents At Carrying Value | $80.9M | $55.5M | $80.3M | $52.2M | $101.1M | $92.8M | $15.0M | |
| Marketable Securities Unrealized Gain Loss | -$111.0K | $961.0K | $3.2M | -$4.0M | -$3.0K | -$7.0K | ||
| Restricted Cash Noncurrent | $2.0M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | |
| Operating Lease Liability Noncurrent | $40.3M | $28.1M | $36.6M | $45.5M | $51.3M | $58.4M | $157.0K | |
| Operating Lease Liability Current | $923.0K | $9.1M | $8.5M | $6.0M | $7.0M | $4.0M | $1.4M | |
| Retained Earnings Accumulated Deficit | -$632.5M | -$558.2M | -$471.6M | -$373.1M | -$264.3M | -$162.9M | -$94.1M | |
| Prepaid Expense And Other Assets Current | $3.1M | $5.9M | $6.1M | $5.6M | $5.3M | $4.9M | $1.4M | |
| Other Assets Noncurrent | $4.0K | $68.0K | $1.1M | $2.4M | $2.4M | $842.0K | $11.0K | |
| Operating Lease Right Of Use Asset | $30.9M | $22.6M | $30.0M | $34.1M | $38.5M | $42.8M | $1.0M | |
| Liabilities Current | $59.7M | $67.0M | $58.4M | $55.2M | $48.7M | $18.8M | $12.7M | |
| Liabilities And Stockholders Equity | $198.1M | $284.0M | $285.9M | $404.9M | $519.8M | $255.6M | $22.3M | |
| Liabilities | $306.6M | $329.5M | $363.1M | $404.8M | $422.9M | $109.4M | $23.8M | |
| Assets Current | $163.2M | $249.6M | $240.2M | $351.4M | $459.6M | $190.7M | $16.9M | |
| Assets | $198.1M | $284.0M | $285.9M | $404.9M | $519.8M | $255.6M | $22.3M | |
| Accounts Payable Current | $4.3M | $3.8M | $6.3M | $5.4M | $3.8M | $3.7M | $3.4M | |
| Marketable Securities | $78.0M | $188.3M | $153.7M | $293.6M | $53.2M | $93.0M | $0.00 | |
| Contract With Customer Liability Noncurrent | $206.0M | $234.5M | $268.1M | $304.0M | $322.7M | $12.5M | ||
| Contract With Customer Liability Current | $43.2M | $45.6M | $34.6M | $32.8M | $28.3M | $2.0M | ||
| Common Stock Value | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $24.0K | $135.0K | -$826.0K | -$4.0M | -$10.0K | -$7.0K | ||
| Accretion Amortization Of Discounts And Premiums Investments | $1.9M | $4.6M | $2.7M | $1.3M | -$179.0K | $1.0K | ||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | $1.9M | $10.0M | $13.0M | $15.3M | $17.6M | $19.5M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Accounts Payable And Other Accrued Liabilities Current | $11.4M | $8.5M | $9.1M | $11.0M | $9.6M | $9.2M | ||
| Restricted Cash Equivalents | $3.3M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | ||
| Other Liabilities Noncurrent | $556.0K | $0.00 | $0.00 | $29.0K | $143.0K | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $27.0M | -$24.9M | $28.1M | -$48.9M | $8.3M | $77.3M | -$23.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$89.7M | -$76.7M | -$61.7M | -$28.3M | -$14.3M | -$97.5M | -$57.4M | -$49.4M | -$24.6M | $24.3M | $47.6M | $72.4M | $81.0M | $104.2M | $125.2M | -$133.3M | -$116.4M | -$101.2M | -$73.8M | -$61.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $92.6M | $75.8M | $62.7M | $59.4M | $140.7M | $81.0M | $72.0M | $59.4M | $52.3M | $89.3M | $62.9M | $215.4M | $59.6M | $126.9M | $68.2M | $76.9M | $38.8M | $5.7M | $22.1M | |
| Cash And Cash Equivalents At Carrying Value | $89.3M | $72.6M | $61.0M | $57.7M | $138.9M | $79.3M | $70.3M | $57.7M | $50.6M | $87.6M | $61.2M | $213.6M | $57.8M | $125.2M | $66.4M | $74.6M | $36.6M | $3.4M | $21.5M | |
| Marketable Securities Unrealized Gain Loss | $68.0K | -$58.0K | -$121.0K | $698.0K | $159.0K | $329.0K | $826.0K | $151.0K | $1.1M | -$1.7M | -$2.0M | -$1.2M | -$3.0K | -$16.0K | $13.0K | |||||
| Restricted Cash Noncurrent | $2.0M | $2.0M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | ||||
| Operating Lease Liability Noncurrent | $15.8M | $17.5M | $25.7M | $30.3M | $28.1M | $34.3M | $38.7M | $40.3M | $43.5M | $46.5M | $49.1M | $50.5M | $53.0M | $54.8M | $56.5M | $56.0M | ||||
| Operating Lease Liability Current | $6.8M | $6.2M | $9.1M | $8.8M | $9.1M | $8.7M | $8.4M | $7.7M | $6.3M | $6.7M | $5.7M | $6.1M | $7.0M | $6.8M | $5.8M | $91.0K | ||||
| Retained Earnings Accumulated Deficit | -$610.8M | -$595.0M | -$577.0M | -$538.7M | -$519.6M | -$496.6M | -$447.5M | -$433.1M | -$403.6M | -$344.3M | -$318.5M | -$291.2M | -$235.1M | -$209.0M | -$185.9M | -$142.2M | ||||
| Prepaid Expense And Other Assets Current | $2.6M | $3.9M | $4.8M | $3.8M | $4.4M | $4.9M | $5.6M | $6.2M | $4.7M | $4.2M | $5.3M | $5.1M | $3.1M | $3.4M | $4.4M | $2.6M | ||||
| Other Assets Noncurrent | $5.0K | $6.0K | $24.0K | $848.0K | $1.0M | $1.1M | $1.1M | $1.2M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $1.6M | $211.0K | ||||
| Operating Lease Right Of Use Asset | $10.2M | $10.9M | $21.2M | $24.1M | $25.5M | $28.5M | $31.4M | $31.6M | $32.9M | $36.2M | $36.3M | $37.4M | $39.6M | $40.7M | $41.7M | $43.9M | ||||
| Liabilities Current | $85.1M | $77.8M | $71.3M | $56.8M | $50.9M | $52.1M | $52.0M | $56.6M | $55.8M | $55.2M | $48.0M | $48.2M | $19.3M | $16.4M | $16.3M | $21.3M | ||||
| Liabilities And Stockholders Equity | $205.0M | $226.2M | $258.7M | $308.4M | $328.6M | $255.0M | $313.4M | $339.6M | $372.9M | $433.9M | $456.9M | $488.3M | $186.1M | $208.5M | $229.9M | $142.4M | ||||
| Liabilities | $294.6M | $302.9M | $320.3M | $336.7M | $342.9M | $352.5M | $370.8M | $388.9M | $397.5M | $409.6M | $409.3M | $415.9M | $105.1M | $104.3M | $104.7M | $99.3M | ||||
| Assets Current | $184.1M | $203.8M | $225.4M | $271.2M | $289.6M | $211.5M | $265.4M | $290.5M | $320.7M | $377.8M | $400.1M | $429.8M | $124.0M | $144.7M | $165.3M | $77.8M | ||||
| Assets | $205.0M | $226.2M | $258.7M | $308.4M | $328.6M | $255.0M | $313.4M | $339.6M | $372.9M | $433.9M | $456.9M | $488.3M | $186.1M | $208.5M | $229.9M | $142.4M | ||||
| Accounts Payable Current | $3.2M | $3.3M | $4.1M | $3.5M | $4.8M | $5.6M | $6.5M | $6.9M | $7.3M | $5.3M | $3.6M | $5.1M | $3.8M | $3.4M | $2.9M | $3.6M | ||||
| Marketable Securities | $90.9M | $126.1M | $159.6M | $209.7M | $146.2M | $127.4M | $189.6M | $226.6M | $265.3M | $285.9M | $333.5M | $211.1M | $63.0M | $16.1M | $94.5M | |||||
| Contract With Customer Liability Noncurrent | $193.1M | $206.8M | $222.4M | $249.5M | $259.5M | $266.1M | $280.1M | $292.0M | $298.2M | $307.8M | $312.1M | $317.1M | $12.7M | $13.1M | $11.9M | $13.1M | ||||
| Contract With Customer Liability Current | $65.3M | $59.7M | $51.7M | $33.4M | $31.2M | $31.5M | $28.3M | $33.9M | $33.3M | $33.2M | $30.6M | $30.1M | $1.3M | $910.0K | $2.4M | $1.7M | ||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $1.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $24.0K | -$44.0K | $14.0K | $360.0K | -$338.0K | -$497.0K | -$1.9M | -$2.7M | -$2.9M | -$4.9M | -$3.2M | -$1.2M | -$13.0K | -$10.0K | $6.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $818.0K | $554.0K | $770.0K | -$38.0K | $13.0K | $0.00 | ||||||||||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | $8.7M | $9.5M | $10.4M | $10.5M | $10.8M | $12.2M | $13.8M | $14.6M | $15.2M | $15.9M | $16.5M | $16.9M | $18.3M | $19.0M | $19.5M | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Accounts Payable And Other Accrued Liabilities Current | $9.8M | $8.6M | $6.5M | $11.2M | $6.5M | $6.3M | $8.8M | $8.1M | $8.8M | $10.1M | $8.1M | $7.0M | $7.2M | |||||||
| Restricted Cash Equivalents | $3.3M | $3.3M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | ||||||||
| Other Liabilities Noncurrent | $656.0K | $757.0K | $856.0K | $0.00 | $0.00 | $0.00 | $58.0K | $88.0K | $116.0K | $171.0K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.6M | -$1.1M | -$26.3M | -$11.5M | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.1M | -$1.6M | $112.5M | -$26.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $3.3M | $3.1M | $3.5M | $3.3M | $3.2M | $1.3M | $693.0K |
| Share Based Compensation | $10.4M | $11.9M | $16.2M | $14.3M | $3.0M | $1.7M | |
| Proceeds From Stock Options Exercised | $483.0K | $2.6M | $1.8M | $1.8M | $1.4M | $1.2M | $691.0K |
| Payments To Acquire Property Plant And Equipment | $50.0K | $906.0K | $1.2M | $1.2M | $3.3M | $16.2M | $968.0K |
| Net Cash Provided By Used In Operating Activities | -$86.1M | -$100.4M | -$118.1M | $193.6M | -$50.3M | -$31.3M | -$46.3M |
| Net Cash Provided By Used In Investing Activities | $112.0M | -$29.9M | $144.5M | -$244.3M | $36.2M | -$108.9M | -$964.0K |
| Net Cash Provided By Used In Financing Activities | $1.0M | $105.4M | $1.8M | $1.8M | $22.4M | $217.5M | $24.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.8M | -$1.3M | -$741.0K | $307.0K | $1.8M | $4.7M | $991.0K |
| Increase Decrease In Accrued Liabilities | $2.2M | -$564.0K | -$1.8M | $1.4M | $2.7M | $3.2M | $2.1M |
| Increase Decrease In Accounts Payable | $481.0K | -$2.5M | $846.0K | $1.6M | $135.0K | $474.0K | $1.2M |
| Increase Decrease In Contract With Customer Liability | -$30.9M | -$22.6M | -$34.2M | -$14.2M | $336.5M | $14.6M | |
| Payments To Acquire Marketable Securities | $131.2M | $261.5M | $73.9M | $409.3M | $100.0M | $93.0M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $243.3M | $232.5M | $219.6M | $166.2M | $139.5M | $0.00 | |
| Increase Decrease In Operating Lease Right Of Use Asset | $5.7M | $5.2M | $4.6M | $4.3M | $4.2M | $1.1M | |
| Increase Decrease In Operating Lease Liability | -$6.7M | -$7.9M | -$7.5M | ||||
| Increase Decrease In Operating Lease Liabilities | -$7.5M | -$7.0M | -$4.0M | $15.1M | -$1.2M | ||
| Increase Decrease In Contract With Customer Asset | $0.00 | -$300.0M | $300.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $900.0K | $900.0K | $827.0K | $700.0K | $800.0K | $835.0K | $900.0K | $800.0K | $859.0K | $900.0K | $800.0K | $811.0K | $800.0K | $800.0K | $772.0K | $300.0K | $200.0K | $255.0K | |
| Share Based Compensation | $2.7M | $2.7M | $2.7M | $3.0M | $3.2M | $3.2M | $4.1M | $4.5M | $4.6M | $3.8M | $3.5M | $3.2M | $2.4M | $2.0M | $1.9M | $877.0K | $489.0K | $517.0K | $443.0K |
| Proceeds From Stock Options Exercised | $139.0K | $1.2M | $102.0K | $384.0K | $62.0K | $247.0K | |||||||||||||
| Payments To Acquire Property Plant And Equipment | $28.0K | $101.0K | $636.0K | $247.0K | $1.8M | $1.0M | |||||||||||||
| Net Cash Provided By Used In Operating Activities | -$24.0M | -$29.3M | -$31.2M | $271.5M | -$23.1M | -$10.8M | |||||||||||||
| Net Cash Provided By Used In Investing Activities | $29.4M | $27.1M | $29.5M | -$159.4M | -$3.3M | -$1.0M | |||||||||||||
| Net Cash Provided By Used In Financing Activities | $139.0K | $1.2M | $102.0K | $384.0K | $62.0K | $247.0K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.1M | -$1.3M | -$887.0K | -$184.0K | $295.0K | $64.0K | |||||||||||||
| Increase Decrease In Accrued Liabilities | -$2.4M | -$2.8M | -$2.2M | -$2.5M | -$2.6M | -$17.0K | |||||||||||||
| Increase Decrease In Accounts Payable | $284.0K | -$629.0K | $1.7M | $1.3M | -$754.0K | $969.0K | |||||||||||||
| Increase Decrease In Contract With Customer Liability | -$6.0M | -$5.1M | -$5.3M | -$3.9M | -$286.0K | $0.00 | |||||||||||||
| Payments To Acquire Marketable Securities | $51.1M | $31.3M | $26.2M | $212.3M | $26.5M | $0.00 | |||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $80.6M | $58.5M | $56.4M | $53.1M | $25.0M | $0.00 | |||||||||||||
| Increase Decrease In Operating Lease Right Of Use Asset | $1.4M | $1.4M | $1.2M | $1.1M | $1.1M | $608.0K | |||||||||||||
| Increase Decrease In Operating Lease Liability | -$2.3M | -$2.1M | -$1.7M | -$1.8M | |||||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$1.8M | -$11.0K | $859.0K | ||||||||||||||||
| Increase Decrease In Contract With Customer Asset | $0.00 | -$300.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.18 | -$1.58 | -$2.34 | -$2.62 | -$2.73 | -$6.23 | -$12.20 |
| Weighted Average Number Of Shares Outstanding Basic | 63.0M | 54.9M | 42.0M | 41.6M | 37.2M | 11.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 63.0M | 54.9M | 42.0M | 41.6M | 37.2M | 11.0M | |
| Earnings Per Share Basic | $-1.18 | $-1.58 | $-2.34 | $-2.62 | $-2.73 | $-6.23 | |
| Common Stock Shares Outstanding | 56.7M | 55.6M | 42.3M | 41.8M | 41.3M | 36.8M | 4.9M |
| Common Stock Shares Issued | 56.7M | 55.6M | 42.3M | 41.8M | 41.3M | 36.8M | 5.8M |
| Common Stock Shares Authorized | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 46.6M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.6M |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.6M |
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 28.6M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.25 | -$0.28 | -$0.30 | -$0.31 | -$0.45 | -$0.59 | -$0.34 | -$0.70 | -$0.73 | -$0.62 | -$0.66 | -$0.65 | -$0.71 | -$0.63 | -$0.62 | -$3.12 | -$2.90 | -$2.71 | -$3.05 |
| Weighted Average Number Of Shares Outstanding Basic | 63.0M | 63.0M | 62.8M | 62.6M | 51.6M | 42.4M | 42.0M | 41.8M | 41.8M | 41.7M | 41.5M | 41.4M | 37.0M | 36.8M | 36.8M | 5.9M | 5.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 63.0M | 63.0M | 62.8M | 62.6M | 51.6M | 42.4M | 42.0M | 41.8M | 41.8M | 41.7M | 41.5M | 41.4M | 37.0M | 36.8M | 36.8M | 5.9M | 5.4M | ||
| Earnings Per Share Basic | $-0.25 | $-0.28 | $-0.30 | $-0.31 | $-0.45 | $-0.59 | $-0.34 | $-0.70 | $-0.73 | $-0.62 | $-0.66 | $-0.65 | $-0.71 | $-0.63 | $-0.62 | $-3.12 | $-2.90 | ||
| Common Stock Shares Outstanding | 56.5M | 55.8M | 55.7M | 55.6M | 55.3M | 42.6M | 42.2M | 41.9M | 41.8M | 41.8M | 41.6M | 41.4M | 37.0M | 36.9M | 36.8M | 6.0M | |||
| Common Stock Shares Issued | 56.5M | 55.8M | 55.7M | 55.6M | 55.3M | 42.6M | 42.2M | 41.9M | 41.8M | 41.8M | 41.6M | 41.4M | 37.0M | 36.9M | 36.8M | 6.2M | |||
| Common Stock Shares Authorized | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 62.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.4M | $11.9M | $16.2M | $14.3M | $8.4M | $3.0M | $1.7M |
| Stock Issued During Period Value Stock Options Exercised | $483.0K | $2.6M | $1.8M | $1.8M | $1.4M | $1.2M | $691.0K |
| Interest Income And Other Income Expense | $3.4M | $4.2M | $2.8M | $2.6M | $2.6M | $1.0M | $495.0K |
| Additional Paid In Capital | $523.9M | $512.5M | $395.2M | $377.2M | $361.1M | $309.1M | $6.1M |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $22.0K | $35.0K | $160.0K | $295.0K | $2.4M | $367.0K |
| Interest Income Other | $8.7M | $11.9M | $10.9M | $5.7M | $59.0K | ||
| Interest Paid Net | $3.6M | $0.00 | $1.7M | $660.0K | $420.0K | ||
| Paid In Kind Interest | $0.00 | $318.0K | $238.0K | $99.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.7M | $2.7M | $2.7M | $3.0M | $3.2M | $3.2M | $4.1M | $4.5M | $4.6M | $3.8M | $3.5M | $3.2M | $2.4M | $2.0M | $1.9M | $877.0K | $489.0K | $517.0K | $443.0K |
| Stock Issued During Period Value Stock Options Exercised | $49.0K | $254.0K | $139.0K | $1.4M | $0.00 | $1.2M | $1.4M | $102.0K | $102.0K | $334.0K | $1.0M | $384.0K | $505.0K | $111.0K | $62.0K | $578.0K | $27.0K | $247.0K | $138.0K |
| Interest Income And Other Income Expense | $620.0K | $852.0K | $1.4M | $1.2M | $783.0K | $739.0K | $721.0K | $712.0K | $720.0K | $651.0K | $650.0K | $655.0K | $680.0K | $645.0K | $630.0K | $394.0K | $14.0K | $29.0K | $121.0K |
| Additional Paid In Capital | $521.1M | $518.3M | $515.3M | $510.0M | $505.6M | $399.6M | $392.0M | $386.5M | $381.9M | $373.4M | $369.3M | $364.8M | $316.1M | $313.2M | $311.1M | $8.9M | |||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $298.0K | $239.0K | $959.0K | $1.5M | ||||||||||||||
| Interest Income Other | $2.0M | $2.3M | $2.7M | $3.5M | $2.9M | $2.4M | $2.8M | $2.8M | $2.7M | $1.8M | $1.2M | $235.0K | |||||||
| Interest Paid Net | $0.00 | $400.0K | $190.0K | ||||||||||||||||
| Paid In Kind Interest | $0.00 | $85.0K | $64.0K |
Most recent annual filing with the SEC: March 11, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.